2021
DOI: 10.1016/j.ajem.2020.05.016
|View full text |Cite
|
Sign up to set email alerts
|

Place of prefilled syringes in COVID-19 patient based on current evidence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
19
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(19 citation statements)
references
References 5 publications
0
19
0
Order By: Relevance
“…30 These conditions can be exacerbated during the COVID-19 pandemic, where clinicians face increased pressures and scarcity of resources during emergency situations. 6 …”
Section: Ismp Surveys and Recommendations Related To IV Push Medication Administrationmentioning
confidence: 99%
See 3 more Smart Citations
“…30 These conditions can be exacerbated during the COVID-19 pandemic, where clinicians face increased pressures and scarcity of resources during emergency situations. 6 …”
Section: Ismp Surveys and Recommendations Related To IV Push Medication Administrationmentioning
confidence: 99%
“…The use of manufacturer-prepared RTA prefilled syringes, where appropriate, can play an important role in reducing errors and increasing efficiency. 6 …”
Section: Ismp Surveys and Recommendations Related To IV Push Medication Administrationmentioning
confidence: 99%
See 2 more Smart Citations
“…This was achieved by standardisation and simplification of the prescriptions. Hospital pharmacy was involved in the preparation of premixed infusions of inotropes and sedatives to minimise workload at the bed spaces [8]. Wherever there was an alternative medication allowing for less frequent or less burdensome administration, the change of prescription was sought.…”
Section: The Aimmentioning
confidence: 99%